Yescarta goes to China as Fosun Kite nabs historic first CAR-T OK

The CAR-T era has officially arrived in China.

Kite Pharma — which had lost out to Novartis in the battle for first FDA approval by just two months — can now claim a historic first at the National Medical Products Administration, where its joint venture with Fosun steered Yescarta to...

Click to view original post